You are here

Roche

Zolgensma flatlines, but Spinraza isn’t the beneficiary

EP Vantage

Wed, 04/28/21 - 10:27 am

What caused Roche's Huntington's drug tominersen to hit the skids in late-stage test? It's complicated, analysts say

Endpoints

Wed, 04/28/21 - 10:22 am

Huntington's disease

FDA panel questions Roche’s Tecentriq-Abraxane combo in breast cancer, but votes to keep approval in place for now

Fierce Pharma

Tue, 04/27/21 - 11:37 pm

accelerated approvals

What are Merck, Bristol Myers and Roche planning for the big FDA cancer approval review?

Fierce Pharma

Tue, 04/27/21 - 11:04 am

accelerated approvals

Bristol Myers Squibb

FDA Advisory Committee to Review Checkpoint Inhibitors Greenlit Under Accelerated Approval

BioSpace

Sun, 04/25/21 - 01:56 pm

accelerated approvals

Bristol Myers Squibb

Roche's virtual gala raises multiple sclerosis awareness with celebrities—and personal connections

Fierce Pharma

Sun, 04/25/21 - 01:46 pm

pharma marketing

multiple sclerosis

The retreat of corporate venture funding?

EP Vantage

Fri, 04/23/21 - 11:02 am

venture funding

venture capital

Boehringer Ingelheim

Bristol Myers Squibb

A look ahead at the FDA meeting that could decide the future of 6 cancer drug approvals

BioPharma Dive

Thu, 04/22/21 - 11:52 pm

cancer immunotherapy

Bristol Myers Squibb

Roche sees a slight dip in Q1 as biosimilars keep biting into blockbuster oncology trio's sales

Endpoints

Wed, 04/21/21 - 10:40 am

Roche culls 2 COVID-19 drug hopefuls amid Q1 clear-out

Fierce Biotech

Wed, 04/21/21 - 10:39 am

Looking to cement its lead in packed MS market, Roche's Ocrevus uncorks new data in early-stage patients

Endpoints

Fri, 04/16/21 - 09:57 am

multiple sclerosis

clinical trials

6 medtechs to watch when earnings kick off next week

Medtech Dive

Fri, 04/16/21 - 09:49 am

Edwards Lifesciences

Intuitive Surgical

Quest Diagnostics

Novartis inks 3rd COVID-19 production pact, this time for Roche's arthritis med Actemra

Fierce Pharma

Thu, 04/15/21 - 11:21 am

Evrysdi has ‘real world impact’ on lives of babies with severe SMA, says Roche

Pharmaforum

Thu, 04/15/21 - 10:02 am

Senti Biosciences in $645M Spark pact to drive gene circuits into the fast lane

Fierce Biotech

Wed, 04/14/21 - 09:34 am

Spark Therapeutics

Senti Biosciences

5 takeaways from AACR, one of the year's top meetings on cancer drugs

BioPharma Dive

Mon, 04/12/21 - 11:34 pm

Bristol Myers Squibb

Pharma's pandemic reputation gains score a 'most-improved' medal in annual ranking

Fierce Pharma

Mon, 04/12/21 - 10:58 pm

pharma industry

Bristol Myers Squibb

Genentech aims high with new diversity goals, including doubling hires and spending $1B with diverse suppliers

Fierce Pharma

Thu, 04/1/21 - 11:37 pm

Go or no go? The FDA plays hardball

EP Vantage

Tue, 03/30/21 - 11:47 am

Bristol Myers Squibb

accelerated approvals

Why Roche's $1.8 Billion Acquisition of GenMark Is a Smart Move

Motley Fool

Wed, 03/24/21 - 10:01 am

Pages